Edesa Biotech, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
British Columbia, Canada
Country
Ontario, Canada
Business Address
100 SPY COURT, MARKHAM, ,
Mailing Address
100 SPY COURT, MARKHAM, ,
Phone
(905) 475-1234
Fiscal Year End
0930
EIN
000000000
Financial Overview
FY2025
$10.80M
Cash & Equivalents
$-1.27
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 3, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
Annual Reports
10-K
December 12, 2025
- Secured capital through various channels including preferred stock, warrants, and ATM offerings.
- Utilized a revolving credit facility and participated in the Canada Emergency Business Account Program (CEBA).
Insider Trading
BUY
2 insiders
9 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.